SINGAPORE (July 13): The hike in average selling prices (ASPs) of Malaysian-based glove makers makes UG Healthcare a counter to watch, notes CGS-CIMB analyst Ong Khang Chuen.
“UG Healthcare remains our preferred pick among the Singapore-listed rubber glove sector, due to its undemanding valuation (a c.60% discount to the Malaysia-listed glove sector average CY21F P/E of 29.3x),” he says in a July 8 note.
Specifically, he believes the counter is able to a garner stronger average selling price (ASP) upside potential than its peers.
